Hospital bottom lines: Why clinical trial enrollment is abysmal

To help reshape the severely flawed U.S. clinical trial system (see above), physicians need better incentives to enroll their patients, said Dr. Roxana Mehran, a cardiology professor hailing from Icahn School of Medicine.  Here’s why: Fifteen percent of clinical trial sites don’t enroll patients at all, Mehran said at this week’s AdvaMed conference in Chicago.  On the flip side, … Continue reading Hospital bottom lines: Why clinical trial enrollment is abysmal